Coronavirus Infection
Conditions
Keywords
Rehabilitation, Coronavirus
Brief summary
To evaluate pulmonary changes and the results of a cardiopulmonary rehabilitation protocol (CPRP) in patients after SARS-VOC-2 infection. Clinical trial type study to be conducted between 2020 and 2024 involving clinical-functional cardiopulmonary imaging and blood transcriptome profile: before CPRP (T1), 2 months after CPRP (T2) and 1 year later (T3). Expected results: a) clinical, image and transcriptome changes; b) clinical-functional improvement after CPRP.
Interventions
OTHERExercise
Exercise with treadmil and weight training station
Sponsors
Universidade Metodista de Piracicaba
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Exercise
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* With confirmed diagnosis for SARS-COV-2.
Exclusion criteria
* With any type of simultaneous pneumopathy. * Patients with autoimmune disease * People with simultaneous infectious diseases * Pregnant women * With degenerative diseases of the nervous system or musculoskeletal system
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Characteristics of lung | post treatment in 3 days | In the supine position, the patient will perform deep inspiration followed by momentary apnea inside the high resolution scanner to capture cross-sectional images of the chest with smaller cuts than 1mm of collimation which helped in the detection of even small lesions. |
| Respiratory muscle strength | post treatment in 3 days | Respiratory muscle strength will be assessed using the digital manovacuometer. The measurement will be performed as follows the patient will be asked to empty the lungs to the residual volume and then perform an inhalation until the total lung capacity. |
Countries
Brazil
Outcome results
None listed